Table 2.
Factors | Number | MiR-93 expression | χ 2 | P value | |
---|---|---|---|---|---|
High | Low | ||||
Age | |||||
<58 | 47 | 15 | 32 | 0.603 | 0.437 |
≥58 | 56 | 22 | 34 | ||
Gender | |||||
Male | 99 | 36 | 63 | 0.000 | 1.000 |
Female | 4 | 1 | 3 | ||
Tumour grade | |||||
G1 + G2 | 37 | 17 | 20 | 2.520 | 0.112 |
G3 | 66 | 20 | 46 | ||
Tumour site | |||||
Glottic | 57 | 21 | 36 | 0.047 | 0.829 |
Others | 46 | 16 | 30 | ||
T classification | |||||
T1 + T2 | 52 | 10 | 42 | 12.711 | <0.001* |
T3 + T4 | 51 | 27 | 24 | ||
Lymph node involvement | |||||
Positive | 39 | 22 | 17 | 11.446 | 0.001* |
Negative | 64 | 15 | 49 | ||
Clinical stage | |||||
I + II | 41 | 7 | 34 | 10.513 | 0.001* |
III + IV | 62 | 30 | 32 |
P values were determined by the χ 2 test
*P ≤ 0.05 was considered to be statistically significant